OUR PIPELINE

Developing the most precise, targeted cancer therapies. 

These are the targets on which we are focused.

Document

Therapeutic area

NSCLC, Gynecologic & Pancreatic (IMV-M)
Discovery
In-vitro
validation
In-vivo
validation
CMC-Ready
Colorectal, Gastric & Breast (IMV-C)
Discovery
In-vitro
validation
In-vivo
validation
Prostate & Melanoma (IMV-1)
Discovery
In-vitro
validation
In-vivo
validation
Urothelial & Gastrointestinal (IMV-2)
Discovery
In-vitro
validation
In-vivo
validation
Ovarian & Endometrial (IMV-3)
Discovery
In-vitro
validation
In-vivo
validation
Multiple Myeloma, Non-Hodgkin Lymphoma & Chronic Lymphocytic Leukemia (IMV-4)
Discovery
In-vitro
validation
In-vivo
validation
Acute Myeloid Leukemia (IMV-5)
Discovery
In-vitro
validation
In-vivo
validation